Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

SHE:002390 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	6,296	8,629	8,560	9,136	14,423	13,431
Market Cap Growth	-22.43%	0.81%	-6.31%	-36.66%	7.39%	58.53%
Enterprise Value	6,084	8,820	8,932	9,841	15,454	15,772
Last Close Price	3.32	4.47	4.26	4.46	6.95	7.94
PE Ratio	87.03	85.11	29.80	40.72	52.86	77.40
Forward PE	-	26.33	26.33	24.74	29.35	29.35
PS Ratio	1.10	1.43	1.33	1.44	2.23	2.30
PB Ratio	0.90	1.23	1.20	1.29	2.11	2.60
P/TBV Ratio	1.06	1.46	1.41	1.52	2.49	3.28
P/FCF Ratio	11.02	16.92	13.07	21.15	70.63	22.24
P/OCF Ratio	9.44	13.59	10.83	15.46	31.49	18.10
EV/Sales Ratio	1.06	1.46	1.38	1.55	2.39	2.70
EV/EBITDA Ratio	13.56	17.96	14.41	17.33	20.14	24.83
EV/EBIT Ratio	24.35	31.18	22.84	29.57	29.24	39.08
EV/FCF Ratio	10.64	17.29	13.64	22.78	75.68	26.11
Debt / Equity Ratio	0.08	0.11	0.12	0.20	0.21	0.66
Debt / EBITDA Ratio	1.17	1.58	1.33	2.42	1.82	5.37
Debt / FCF Ratio	0.92	1.54	1.28	3.22	6.93	5.65
Asset Turnover	0.66	0.66	0.68	0.65	0.67	0.58
Inventory Turnover	5.18	4.85	5.15	5.22	5.76	5.00
Quick Ratio	2.81	2.23	2.02	1.65	1.56	1.12
Current Ratio	3.58	2.91	2.63	2.16	2.02	1.36
Return on Equity (ROE)	1.76%	2.20%	4.98%	3.86%	6.23%	4.32%
Return on Assets (ROA)	1.79%	1.93%	2.57%	2.14%	3.43%	2.51%
Return on Invested Capital (ROIC)	3.19%	3.40%	4.74%	3.75%	6.51%	4.60%
Return on Capital Employed (ROCE)	3.50%	3.90%	5.40%	4.70%	7.70%	7.80%
Earnings Yield	1.22%	1.18%	3.36%	2.46%	1.89%	1.29%
FCF Yield	9.08%	5.91%	7.65%	4.73%	1.42%	4.50%
Dividend Yield	1.83%	1.34%	1.41%	1.35%	0.86%	-
Payout Ratio	231.87%	189.67%	55.09%	75.03%	84.41%	113.85%
Buyback Yield / Dilution	-7.11%	-5.89%	-2.41%	-2.79%	-15.32%	-0.14%
Total Shareholder Return	-5.28%	-4.55%	-1.00%	-1.44%	-14.46%	-0.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.